Fidelity Investments’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.04M | Sell |
|
|||||
|
2023
Q1 | $10.3M | Sell |
|
|||||
|
2022
Q4 | $12.7M | Sell |
|
|||||
|
2022
Q3 | $29M | Buy |
|
|||||
|
2022
Q2 | $27.7M | Buy |
|
|||||
|
2022
Q1 | $16.3M | Sell |
|
|||||
|
2021
Q4 | $37.1M | Sell |
|
|||||
|
2021
Q3 | $48.3M | Sell |
|
|||||
|
2021
Q2 | $49M | Sell |
|
|||||
|
2021
Q1 | $65.1M | Sell |
|
|||||
|
2020
Q4 | $94.1M | Buy |
|